Negative regulation of ACE2 by interferons in vivo and its genetic control
Ansari, M. A.; Marchi, E.; Ramamurthy, N.; Aschenbrenner, D.; Hackstein, C.-P.; STOP-HCV consortium, ; ISARIC-4C Investigators, ; Lin, S.-K.; Bowden, R.; Sharma, E.; Pedergnana, V.; Venkateswaran, S.; Kugathasan, S.; Mo, A.; Gibson, G.; McLauchlan, J.; Barnes, E.; Baillie, J. K.; Teichmann, S.; Mentzer, A.; Todd, J.; Knight, J.; Uhlig, H.; Klenerman, P.
Show abstract
The SARS-CoV-2 pandemic has resulted in widespread morbidity and mortality globally. ACE2 is a receptor for SARS-CoV-2 and differences in expression may affect susceptibility to COVID-19. Using HCV-infected liver tissue from 195 individuals, we discovered that among genes negatively correlated with ACE2, interferon signalling pathways were highly enriched and observed down-regulation of ACE2 after interferon-alpha treatment. Negative correlation was also found in the gastrointestinal tract and in lung tissue from a murine model of SARS-CoV-1 infection suggesting conserved regulation of ACE2 across tissue and species. Performing a genome-wide eQTL analysis, we discovered that polymorphisms in the interferon lambda (IFNL) region are associated with ACE2 expression. Increased ACE2 expression in the liver was also associated with age and presence of cirrhosis. Polymorphisms in the IFNL region may impact not only antiviral responses but also ACE2 with potential consequences for clinical outcomes in distinct ethnic groups and with implications for therapeutic interventions.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Liver Sinusoidal Endothelial Cells and Laminin dictate cholangiocytes fate in chronic liver disease 91%
- A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts 91%
- An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma 90%
Similar papers in this journal
- Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients 91%
- VHL synthetic lethality screens uncover CBF-beta as a negative regulator of STING 91%
- Nuclear RNA exosome targeting onto chromatin loci in the degradation of unstable transcripts affects transcriptional programs in liver cells. 90%
Similar papers in this journal
- A single-cell fixed RNA profiling of liver fibrosis progression and regression reveals SEMA4D and LMCD1 as key mediators of fibrogenesis 92%
- Constitutive Androstane Receptor contributes towards increased drug clearance in cholestasis 92%
- The beta-catenin-target Fascin-1, altering hepatocyte differentiation, is a new marker of immature cells in hepatoblastomas 91%
Similar papers in this journal
- A phosphoproteomic approach reveals that PKD3 controls phenylalanine and tyrosine metabolism 89%
- Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist. 88%
- BRD2 regulation of sigma-2 receptor expression upon cytosolic cholesterol deprivation 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.